Ultra-hypofractionated radiotherapy for the treatment of localized prostate cancer: Results, limits and prospects von Graff, P., Crehange, G.

Volltext

SP-0099 PROMISES AND PITFALLS OF FUNCTIONAL IMAGING FOR FOCAL DOSE ESCALATION IN PROSTATE CANCER von Crehange, G

Volltext

SP-0359 Locally advanced oesophagus where more is not better von Crehange, G.

Volltext

French ccAFU guidelines - update 2020-2022: prostate cancer von Rozet, F., Mongiat-Artus, P., Hennequin, C., Beauval, J. B., Beuzeboc, P., Cormier, L., Fromont-Hankard, G., Mathieu, R., Ploussard, G., Renard-Penna, R., Brenot-Rossi, Bruyere, F., Cochet, A., Crehange, G., Cussenot, O., Lebret, T., Rebillard, X., Soulie, M., Brureau, L., Mejean, A.

Volltext

Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation von Meraouna, Y., Blanchard, P., Losa, S., Labib, A., Krhili, S., Pommier, P., Crehange, G., Flam, T., Cosset, J-M., Kissel, M.

Volltext

Dose-escalation in prostate cancer: Results of randomized trials von Kissel, M., Krhili, S.-L., Minsat, M., El Ayachy, R., Bringer, S., Lahmi, L., Porte, J., Labib, A., Graff, P., Crehange, G.

Volltext

Focal Nodal SBRT or Elective Nodal Protracted Salvage Radiation Therapy for Prostate Cancer Patients With a Choline PET-CT Positive Nodal Relapse von Crehange, G, Maingon, P, Cueff, A, Truc, G, Peignaux, K, Mazoyer, F, Vulquin, N, Quivrin, M, Naudy, S, Martin, E

Volltext

Chemoradiation Therapy for Esophageal Cancer in Elderly Patients von Servagi Vernat, S, Crehange, G, Roullet, B, Puyraveau, m, Buffet Miny, J, Bosset, J

Volltext

2069 Elective nodal irradiation during exclusive chemoradiation for locally-advanced esophageal cancer: IMRT better spares critical organs at risk von Jean-Mary, E, Dalban, C, Serre, A.A, Maingon, P, Petitfils, A, Mirjolet, C, Vulquin, N, Wiazzane, N, Crehange, G

Volltext

Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the... von Belkacemi, Y., Latorzeff, I., Hasbini, A., Coraggio, G., Pasquier, D., Toledano, A., Hennequin, C., Bossi, A., Chapet, O., Crehange, G., Guerif, S., Duberge, T., Allouache, N., Clavere, P., Gross, E., Supiot, S., Azria, D., Bolla, M., Sargos, P.

Volltext

Secondary neutron dose contribution from pencil beam scanning, scattered and spatially fractionated proton therapy von Leite, A M M, Ronga, M G, Giorgi, M, Ristic, Y, Perrot, Y, Trompier, F, Prezado, Y, Créhange, G, De Marzi, L

Volltext

Corrigendum to “French ccAFU guidelines–update 2020–2022: Prostate cancer” [Prog. Urol 30 (12 S) (2020), pp S136-S251] von Rozet, F., Mongiat-Artus, P., Hennequin, C., Beauval, J.B., Beuzeboc, P., Cormier, L., Fromont-Hankard, G., Mathieu, R., Ploussard, G., Renard-Penna, R., Brenot-Rossi, I., Bruyere, F., Cochet, A., Crehange, G., Cussenot, O., Lebret, T., Rebillard, X., Soulié, M., Brureau, L., Méjean, A.

Volltext

The Relationship Between the Occurrence of Bone Metastases and Dose/Volume of Prior Prostate Radiation Therapy in Patients With Localized Prostate Cancer von Crehange, G, Laporte, G, Dalban, C, Martin, E, Cochet, A, Cormier, L, Mirjolet, C, Desmoulins, I, Ladoire, S, Maingon, P

Volltext

Which PSA Endpoint Best Predicts Disease-Free Survival in Prostate Cancer Patients Treated With Exclusive Radiation Therapy Combined With Hormones? von Thouant, M, Bertaut, A, Pommier, P, Maingon, P, Martin, E, Quivrin, M, Vulquin, N, Ladoire, S, Cormier, L, Carrie, C, Crehange, G

Volltext

207 The enhancement of radiotherapy efficacy with docetaxel-titanate nanotubes as a new nanohybrid for localized high risk prostate cancer von Mirjolet, C, Boudon, J, Loiseau, A, Chevrier, S, Gautier, T, Boidot, R, Paris, J, Millot, N, Crehange, G

Volltext

Postimplant Multiparametric MRI-Based Dosimetry After Permanent Iodine Seed Prostate Brachytherapy: The Impact of the Dose Delivered to the Dominant Intraprostatic Lesion on Prosta... von Quivrin, M, Loffroy, R, Mirjolet, C, Cueff, A, Sottier, D, Bidault, F, Martin, E, Maingon, P, Walker, P, Crehange, G

Volltext

2009 Tumoral lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer as a prognostic factor for survival: The LYMPHOREC study von Mirjolet, C, Charon-barra, C, Arbez-gindre, F, Gauthier, M, Maingon, P, Barthod, Z, Leroux, A, Merlin, J.L, Peiffert, D, Dalban, C, Ladoire, S, Bosset, J.F, Crehange, G

Volltext

PO-0661: Gliosarcoma: prognostic and therapeutics factors von Castelli, J, Feuvret, L, Haoming, Q, Biau, J, Jouglar, E, Berger, A, Truc, G, Guttierrez, F. Llama, Morandi, X, Thillays, F, Loussouarn, D, Lecouillard, I, Crehange, G, Antoni, D, Vauleon, E, De Crevoisier, R, Noë, G

Volltext

PO-1469 dose escalation in hypofractionated radiotherapy in prostate cancer : early and late toxicity von Quintin, K., Crehange, G., Graff, P., Krhili, S.

Volltext

Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiat... von Zhou, K., Renouf, M., Perrocheau, G., Magné, N., Latorzeff, I., Pommier, P., Créhange, G., Paumier, A., Bera, G., Martin, J., Catton, C., Bellanger, M., Supiot, S.

Volltext